Furthermore, on a cell-for-cell basis, T cells with their differentiation withheld by Akt inhibition were superior at eradicating established human and murine tumor after adoptive transfer in both a murine and murine-human xenograft models of adoptive T cell immunotherapy (24, 37, 38). The gene discussed is AKT1; the disease is neoplasm.